An FDA approval could come at a major cost for patients

An FDA approval could come at a major cost for patients

‘A loss for the rest of us’: An FDA approval is a boon for a drug maker, but could come at a major cost for patients

By MEGHANA KESHAVAN

DOM SMITH/STAT

A Florida-based drug maker now has the ability to charge a premium on a drug that has come free or dirt cheap for many patients for decades.

READ MORE